Measles, Mumps and Rubella Vaccine Live
| Brand name | PRIORIX |
|---|---|
| Active ingredient | Measles, Mumps and Rubella Vaccine Live |
| Strength | 3.4, 4.2 and 3.3LOG10 |
| Dosage form | For Injection |
| Route | Subcutaneous |
| Modality | Biologic |
| FDA approval | June 2022 |
| Marketing status | Rx |
Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the projected — 12-year biologic exclusivity estimate; estimates are projections, not legal advice.